These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 21256579)
1. Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors. Weinberg LE; Lurain JR; Singh DK; Schink JC Gynecol Oncol; 2011 May; 121(2):285-9. PubMed ID: 21256579 [TBL] [Abstract][Full Text] [Related]
2. Young girls with malignant ovarian germ cell tumors can undergo normal menarche and menstruation after fertility-preserving surgery and adjuvant chemotherapy. Yoo SC; Kim WY; Yoon JH; Chang SJ; Chang KH; Ryu HS Acta Obstet Gynecol Scand; 2010; 89(1):126-30. PubMed ID: 19878051 [TBL] [Abstract][Full Text] [Related]
3. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases. Low JJ; Perrin LC; Crandon AJ; Hacker NF Cancer; 2000 Jul; 89(2):391-8. PubMed ID: 10918171 [TBL] [Abstract][Full Text] [Related]
4. [Evaluation of the effect of fertility-saving surgery on young patients with malignant ovarian tumors]. Xi MR; Hou MM; Cao ZY; Zhang CS; Peng ZL; Wang HJ; Zheng A Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):233-6. PubMed ID: 16759456 [TBL] [Abstract][Full Text] [Related]
6. Outcomes of pediatric and adolescent girls with malignant ovarian germ cell tumors. Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH Gynecol Oncol; 2015 Jun; 137(3):418-22. PubMed ID: 25842162 [TBL] [Abstract][Full Text] [Related]
7. Conservative treatment of ovarian cancer. Safety, ovarian function preservation, reproductive ability, and emotional attitude of the patients in Saudi Arabia. Sait KH Saudi Med J; 2011 Sep; 32(9):913-8. PubMed ID: 21894353 [TBL] [Abstract][Full Text] [Related]
8. [Results of fertility preserving operations in malignant ovarian tumors]. Kleine W Zentralbl Gynakol; 1996; 118(6):317-21. PubMed ID: 8768006 [TBL] [Abstract][Full Text] [Related]
9. Menstrual function and childbearing potential after fertility-sparing surgery and platinum-based chemotherapy for malignant ovarian germ cell tumours. Gadducci A; Lanfredini N; Tana R Gynecol Endocrinol; 2014 Jul; 30(7):467-71. PubMed ID: 24702194 [TBL] [Abstract][Full Text] [Related]
10. Reproductive function after treatment of ovarian germ cell malignancy. Anita AN; Rushdan MN Med J Malaysia; 2012 Feb; 67(1):71-6. PubMed ID: 22582552 [TBL] [Abstract][Full Text] [Related]
11. [Adjuvant therapy of malignant ovarian tumors after organ preserving surgery]. Schröder W Zentralbl Gynakol; 1996; 118(10):565-70. PubMed ID: 8912476 [TBL] [Abstract][Full Text] [Related]
12. A successful IVF-pregnancy in a patient who underwent conservative surgery followed by a regimen of cisplatin, vinblastine and peplomycin to treat an advanced ovarian mixed germ cell tumour: a case report. Kitajima Y; Endo T; Hayashi T; Ishioka S; Baba T; Honnma H; Saito T Hum Reprod; 2007 Mar; 22(3):850-2. PubMed ID: 17067995 [TBL] [Abstract][Full Text] [Related]
13. A retrospective study of reproductive outcomes after fertility-sparing surgery and postoperative adjuvant chemotherapy in malignant ovarian germ cell tumors and sex cord-stromal tumors. Zhang N; Chen R; Hua K; Zhang Y J Ovarian Res; 2017 Jul; 10(1):52. PubMed ID: 28750644 [TBL] [Abstract][Full Text] [Related]
15. Long-term oncological and reproductive outcomes of fertility-sparing cytoreductive surgery in females aged 25 years and younger with malignant ovarian germ cell tumors. Ertas IE; Taskin S; Goklu R; Bilgin M; Goc G; Yildirim Y; Ortac F J Obstet Gynaecol Res; 2014 Mar; 40(3):797-805. PubMed ID: 24320102 [TBL] [Abstract][Full Text] [Related]
16. Chemotherapy of ovarian germ cell tumors. Williams SD Hematol Oncol Clin North Am; 1991 Dec; 5(6):1261-9. PubMed ID: 1663943 [TBL] [Abstract][Full Text] [Related]
17. Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor. Kang H; Kim TJ; Kim WY; Choi CH; Lee JW; Kim BG; Bae DS Gynecol Oncol; 2008 Oct; 111(1):106-10. PubMed ID: 18656249 [TBL] [Abstract][Full Text] [Related]
18. Pregnancy outcomes and menstrual function after fertility sparing surgery for pure ovarian dysgerminomas. Boran N; Tulunay G; Caliskan E; Köse MF; Haberal A Arch Gynecol Obstet; 2005 Feb; 271(2):104-8. PubMed ID: 15007601 [TBL] [Abstract][Full Text] [Related]
19. An Analysis of Prognostic Factors in Patients with Ovarian Malignant Germ Cell Tumors Who Are Treated with Fertility-Preserving Surgery. Yang ZJ; Liu ZC; Wei RJ; Li L Gynecol Obstet Invest; 2016; 81(1):1-9. PubMed ID: 25967958 [TBL] [Abstract][Full Text] [Related]
20. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study. Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]